Paul Saladino
Paul Saladino is a health content creator and commentator who produces material on nutrition and wellness. His work focuses on animal-based diets, lifestyle optimization, and the health effects of substances such as nicotine. No academic publications were provided in his record.
67 claims checked on air: 11 context 2 contradicted 6 overstated 40 supported 8 unverified
What they said on air - supported
Cigarette manufacturers added bronchodilator compounds to cigarettes to open airways and facilitate deeper inhalation of nicotine into the lungs.
"They also added bronchodilators, pharmaceutical compounds like the ones people with asthma use, to open your airways so you could inhale deeper, so the freebased nicotine in a cigarette could get deeper into your lung." (said at 0:04:28)
Cigarette additives have included substances evaluated and regulated specifically for their bronchodilatory and inhalation-facilitating properties. Published regulatory analyses and pharmacological reviews document that additives such as menthol, methylxanthines (e.g., theobromine from cocoa), and β2-adrenoreceptor agonists have been used or investigated in tobacco products because their bronchodilating, sensory-masking, and airway-relaxing effects facilitate deeper inhalation and enhance nicotine uptake and bioavailability.
- supports: Menthol pharmacology and its potential impact on cigarette smoking behavior. (Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2004) · cited 167x in the literature
"Menthol properties include cooling and local anesthesia, as well as effects on drug absorption and metabolism, bronchodilation and respiration changes, and electrophysiology." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Identifying substances suspected of facilitating inhalation or increasing nicotine uptake … (Tobacco control 2026) · cited 1x in the literature
"The Tobacco Products Directive 2014/40/EU (TPD) introduced rules prohibiting tobacco products and liquids for electronic cigarettes with nicotine which contain substances or additives that facilitate inhalation or nicotine uptake... An extensive list of substances with nicotine inhalation facilitating properties is proposed, containing TRPM8 receptor agonists and β2-adrenoreceptor agonists. Further research on the properties of certain substances, including increased transbuccal permeability, pH alteration and bronchodilator effect, is also suggested." (abstract, results and conclusions, passage verified)
pubmedfull study (doi)
The Royal College of Physicians in the UK concluded that nicotine is not a significant contributor to smoking-related diseases.
"The Royal College of Physicians in the UK has concluded that nicotine is not a significant contributor to smoking-related diseases." (said at 0:06:01)
The Royal College of Physicians (RCP) in the United Kingdom evaluated the health impacts of nicotine and non-combustible delivery systems (such as electronic cigarettes and medicinal nicotine) in major landmark reports, notably 'Nicotine without smoke: Tobacco harm reduction' (2016) and 'Harm reduction in nicotine addiction' (2007). The RCP established that the substantial morbidity and mortality of smoking are overwhelmingly caused by the toxic and carcinogenic products of tobacco combustion (such as tar, carbon monoxide, and volatile organic compounds), rather than nicotine itself. While nicotine is the primary addictive agent in tobacco and produces mild hemodynamic effects, the RCP concluded that nicotine in doses delivered by clean nicotine replacement or non-combustible products is not a significant direct cause of smoking-related cardiovascular disease, chronic obstructive pulmonary disease, or cancer.
Original Juul pods contained about 5% nicotine by weight, equivalent to approximately one pack of cigarettes per pod.
"Juul pods contained about 5% nicotine by weight, equivalent to about a pack of cigarettes in a single Juul pod." (said at 0:07:38)
Standard original JUUL pods in the United States were marketed and formulated with approximately 5% nicotine by weight (about 59 mg/mL, or ~40–48 mg of total nicotine per 0.7 mL pod). Multiple reviews and aerosol studies confirm that one 5% JUUL pod delivers nicotine roughly equivalent to smoking a standard pack of combustible cigarettes (~13 to 30 cigarettes, with a median around 18–20 cigarettes, depending on user puffing behavior and experience).
By 2018, Juul controlled 75% of the US e-cigarette market.
"By 2018, Juul controlled 75% of the e-cigarette market, and "Juuling" was a term well known within every high school in the United States." (said at 0:08:08)
Retail market sales data show that JUUL underwent unprecedented growth in the US e-cigarette market between 2015 and 2018. Having risen to approximately 40% of retail market share by late 2017 and nearly 50% by early 2018, JUUL's share of US retail e-cigarette sales peaked at approximately 70% to 75% by late 2018.
In 2022, Philip Morris acquired Swedish Match, the owner of Zyn, for $16 billion.
"In 2022, Philip Morris acquired Swedish Match, the company that owns Zyn, for $16 billion." (said at 0:09:20)
In November 2022, Philip Morris International (PMI) completed its acquisition of Swedish Match, the manufacturer and owner of the nicotine pouch brand Zyn, in a transaction valued at approximately $16 billion.
Paul Newhouse's research at Vanderbilt University found that nicotine does not enhance cognition in healthy individuals who sleep and eat well.
"This researcher's name is Paul Newhouse. He's a PhD at Vanderbilt University. He's been studying nicotine in the human brain for 30 years and this is what he discovered: that in a healthy person, nicotine does not enhance cognition." (said at 0:10:39)
Paul Newhouse's research on nicotinic stimulation developed the 'baseline dependency' model of nicotine's cognitive effects. In his reviews and empirical studies examining healthy non-smoking individuals versus clinical populations (such as individuals with ADHD, mild cognitive impairment, or Alzheimer disease), Newhouse and colleagues reported that healthy individuals operating at optimal baseline cognitive performance generally do not experience cognitive enhancement from nicotine (and may experience adverse or disruptive effects), whereas individuals with baseline cognitive deficits show significant improvements. Broader literature outside Newhouse's group notes modest acute gains in specific laboratory tasks (such as fine motor speed and orienting attention) in healthy non-smokers, but the claim accurately describes Newhouse's central research findings and conclusions.
- supports: Effects of nicotinic stimulation on cognitive performance. (Current opinion in pharmacology 2004) · cited 406x in the literature
"In contrast to studies in pathological states, studies of nicotine in normal-non-smokers tend to show deleterious effects. This contradiction can be resolved by consideration of cognitive and biological baseline dependency differences between study populations in terms of the relationship of optimal cognitive performance to nicotinic receptor activity. Although normal individuals are unlikely to show cognitive benefits after nicotinic stimulation except under extreme task conditions, individuals with a variety of disease states can benefit from nicotinic drugs." (abstract, results, passage verified)
pubmedfull study (doi) - context: Meta-analysis of the acute effects of nicotine and smoking on human performance. (Psychopharmacology 2010) · cited 653x in the literature
"We conducted a meta-analysis on the outcome measures of 41 double-blind, placebo-controlled laboratory studies published from 1994 to 2008. In all studies, nicotine was administered, and performance was assessed in healthy adult nonsmokers or smokers who were not tobacco-deprived or minimally deprived (<or=2 h)... We found significant positive effects of nicotine or smoking on six domains: fine motor, alerting attention-accuracy and response time (RT), orienting attention-RT, short-term episodic memory-accuracy, and working memory-RT" (abstract, results, passage verified)
pubmedfull study (doi)
Research shows that nicotine supplementation can improve cognitive function in individuals with mild cognitive impairment or dementia.
"Now, for the sake of completeness, I want to point out that in their research, they have shown that if your cognition is impaired, if you have mild dementia or memory issues, nicotine supplementation may be helpful." (said at 0:11:35)
Randomized clinical trial evidence supports the claim that nicotine supplementation may improve cognitive measures in individuals with mild cognitive impairment (MCI). In a 6-month double-blind pilot randomized controlled trial of 74 nonsmoking individuals with amnestic MCI (Newhouse et al., 2012), transdermal nicotine (15 mg/day) led to statistically significant improvements in primary cognitive measures of attention as well as secondary measures of memory and psychomotor speed compared to placebo, although it did not produce statistically significant changes on clinician-rated global impressions.
Getting the amount of nicotine found in a single cigarette requires eating 20 pounds of eggplant.
"All of these foods contain naturally occurring nicotine. But to get the amount of nicotine found in a single cigarette, you would have to eat 20 pounds of eggplant." (said at 0:12:08)
Dietary plants in the Solanaceae family (such as eggplants, tomatoes, and potatoes) naturally contain small amounts of nicotine. Seminal analytical measurements published in the New England Journal of Medicine (Domino et al., 1993; PMID: 8326992, 'The nicotine content of common vegetables') established that fresh eggplant contains approximately 100 ng of nicotine per gram of wet weight (equivalent to 100 µg/kg or 0.1 mg/kg). Because a standard smoked cigarette delivers roughly 1 mg of bioavailable nicotine to a smoker, consuming 1 mg of nicotine from eggplant requires eating approximately 10 kg, which equals approximately 22 pounds (rounded commonly to 20 pounds).
No nicotine is naturally produced in the human body; the endogenous ligand for the nicotinic acetylcholine receptor is acetylcholine.
"There is actually no nicotine naturally produced in the human body. But this receptor is called a nicotinic acetylcholine receptor based on historical research where researchers used nicotine to activate the receptor. The actual endogenous ligand, the thing in your body that binds to the nicotinic acetylcholine receptor, is acetylcholine." (said at 0:12:49)
Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand-gated ion channels whose primary endogenous neurotransmitter/ligand is acetylcholine. Nicotine is an exogenous alkaloid produced by Solanaceae plants (such as tobacco) that historically served as a pharmacological tool (alongside muscarine) to distinguish receptor subtypes, and it is not endogenously biosynthesized in the human body.
Nicotine crossing the blood-brain barrier and binding to nicotinic acetylcholine receptors triggers the release of dopamine, norepinephrine, and beta-endorphin.
"When exogenous nicotine from any one of these sources crosses the blood-brain barrier and binds to these nicotinic acetylcholine receptors in your brain, it triggers the release of multiple other neurotransmitters. Most importantly, dopamine, associated with reward and motivation. Anything that triggers the release of dopamine in your body is very addictive. Caffeine, anyone? Nicotine also triggers the release of norepinephrine, associated with alertness and focus, and beta-endorphin, which is linked to pain relief and calm." (said at 0:13:18)
Extensive pharmacological and neurochemical research establishes that exogenous nicotine readily crosses the blood-brain barrier and binds to nicotinic acetylcholine receptors (nAChRs) in the central nervous system. This activation stimulates the release of multiple neurotransmitters and neurohormones, including dopamine (particularly in the mesolimbic reward pathway), norepinephrine (noradrenaline), and beta-endorphin.
A 2010 meta-analysis by Heishman of 41 double-blind placebo-controlled trials found cognitive effect sizes of nicotine supplementation ranged from 0.16 to 0.44.
"There's a 2010 meta-analysis by Heishman that did find benefits to nicotine supplementation... The effect sizes were 0.16 to 0.44. That's small to moderate in scientific research terms." (said at 0:13:51)
A 2010 meta-analysis by Heishman and colleagues evaluated 41 double-blind, placebo-controlled laboratory studies of acute nicotine administration in healthy adult non-smokers or non-deprived smokers. The analysis identified significant positive effects across six performance domains (fine motor abilities, alerting attention accuracy/response time, orienting attention response time, short-term episodic memory accuracy, and working memory response time), with effect sizes ranging from 0.16 to 0.44.
A 2020 systematic review found that 59% of researchers publishing studies on nicotine's cognitive benefits had tobacco industry funding, and over half did not disclose it.
"a 2020 systematic review found that 59% of researchers publishing studies on the cognitive benefits of nicotine had prior or current tobacco industry funding. And over half of them didn't disclose it." (said at 0:16:49)
A 2020 systematic review evaluating cognitive performance effects of nicotine and industry affiliations found that among 32 included studies, 59% (n = 19) of authors had received prior tobacco industry funding, and 53% (n = 10) of those with industry funding did not disclose it.
Daily nicotine use causes the brain to upregulate and produce more nicotinic acetylcholine receptors.
"When you flood your nicotinic acetylcholine receptors with nicotine day after day, an interesting thing happens. The nicotine actually causes your brain to produce more of these receptors, but they're stuck in a state that needs nicotine to function properly." (said at 0:17:13)
Chronic or daily exposure to nicotine reliably causes upregulation of high-affinity neuronal nicotinic acetylcholine receptors (nAChRs, particularly the α4β2 subtype) throughout the brain. This paradoxical increase in receptor density is a well-established neuroadaptation accompanied by receptor desensitization and intracellular pharmacological chaperoning by nicotine, which stabilizes receptor assembly and alters normal receptor function and sensitivity.
- supports: Nicotine enhances intracellular nicotinic receptor maturation: a novel mechanism of neural… (Journal of physiology, Paris 2006) · cited 86x in the literature
"Upon chronic exposure, nicotine elicits a cascade of events, starting with nAChR activation and desensitization, followed by a long term up-regulation that corresponds to an increase in the number of the high affinity nAChRs, a paradoxical process that occurs in the brain of smokers." (abstract, passage verified)
pubmedfull study (doi) - supports: Inside-out neuropharmacology of nicotinic drugs. (Neuropharmacology 2015) · cited 102x in the literature
"Upregulation of neuronal nicotinic acetylcholine receptors (AChRs) is a venerable result of chronic exposure to nicotine; but it is one of several consequences of pharmacological chaperoning by nicotine and by some other nicotinic ligands, especially agonists." (abstract, passage verified)
pubmedfull study (doi) - supports: Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction. (Neuropharmacology 2020) · cited 193x in the literature
"Chronic nicotine exposure results in numerous neuroadaptations, including the upregulation of particular nAChR subtypes associated with long-term desensitization of the receptors." (abstract, passage verified)
pubmedfull study (doi)
A 2025 review in the European Heart Journal concluded that no nicotine delivery system can be considered safe for cardiovascular health.
"According to the scientific literature, a 2025 review in the European Heart Journal concluded that no nicotine delivery system—not cigarettes, not vaping, not nicotine pouches—can be considered safe for the heart and blood vessels." (said at 0:19:10)
A 2025 expert consensus and policy statement published in the European Heart Journal evaluated the cardiovascular impacts of nicotine across various delivery mechanisms. The authors concluded that nicotine itself acts as a direct cardiovascular toxin independent of combustion, noting that all nicotine delivery systems—including traditional cigarettes, electronic cigarettes, heated tobacco, and nicotine pouches—pose substantial cardiovascular risks and that the concept of 'safer nicotine' is misleading.
A 2024 study found that e-cigarette users were 20% more likely to develop heart failure.
"A 2024 study found that e-cigarette users were 20% more likely to develop heart failure." (said at 0:19:58)
The statement accurately reflects findings presented in 2024 from a large observational study using the NIH 'All of Us' Research Program dataset (175,667 participants, presented at the American College of Cardiology Scientific Session 2024 by Bene-Alhasan et al.). That study reported that participants who used e-cigarettes had a 19% higher risk (often reported as ~20%; HR 1.19) of developing incident heart failure, particularly heart failure with preserved ejection fraction (HFpEF), compared with non-users. Published 2024 reviews also document that e-cigarette use is associated with an increased incidence of cardiovascular conditions, including heart failure. Because the primary findings derive from an observational cohort design and conference presentation data, certainty is rated as low.
A 2024 study in Communications Biology found adolescent nicotine exposure produces qualitatively different brain effects in the prefrontal cortex, nucleus accumbens, and ventral tegmental area compared to adults.
"A 2024 study in Nature's Communications Biology journal found that adolescent exposure to nicotine affects the brain very differently than adult exposure: qualitatively different effects in the prefrontal cortex, the nucleus accumbens, and the ventral tegmental area." (said at 0:21:30)
A 2024 animal study published in Communications Biology (a Nature Portfolio journal) compared the effects of vaporized nicotine self-administration in adolescent versus adult mice across the prefrontal cortex (mPFC), ventral tegmental area (VTA), and nucleus accumbens. The researchers found distinct, age-dependent neurobiological changes: adolescent-exposed mice showed significant increases in mPFC pyramidal neuron excitability that correlated with reinforcement-related behavior, whereas adult-exposed mice showed distinct receptor alterations in the VTA correlating with self-administration. Because the evidence is derived exclusively from a rodent model, the certainty of direct translation to human brain function is very low.
Cigarette smoking causes approximately 480,000 deaths per year in the United States.
"Let's start with cigarettes: combustion, 7,000 chemicals, 70 known carcinogens, 480,000 American deaths per year." (said at 0:22:06)
Epidemiological estimates from the US Centers for Disease Control and Prevention and the US Preventive Services Task Force establish that cigarette smoking (including exposure to secondhand smoke) is responsible for approximately 480,000 deaths annually in the United States.
Vaping delivers 13 times lower formaldehyde and 800 times lower acetaldehyde levels than combustible cigarettes.
"Formaldehyde 13 times lower than cigarettes. Acetaldehyde 800 times lower than cigarettes." (said at 0:22:21)
Laboratory aerosol analyses comparing electronic cigarettes to combustible tobacco cigarettes show that emissions of key carbonyl toxicants, including formaldehyde and acetaldehyde, are substantially lower in e-cigarette vapor. In benchmark aerosol testing across multiple e-cigarette brands and combustible cigarettes, toxicant emissions in vapor were found to be 9- to 450-fold lower than in conventional cigarette smoke. Although exact ratios vary depending on device power, liquid composition, and operating temperatures (which can alter thermal degradation of carrier solvents like propylene glycol and glycerol), the claimed multi-fold reductions in formaldehyde and acetaldehyde relative to combustible cigarettes are well supported by aerosol chemistry literature.
A single disposable vape can release more lead in one day of use than smoking 20 packs of cigarettes.
"One disposable vape released more lead in a single day's use than 20 packs of cigarettes." (said at 0:22:32)
Chemical analyses of contemporary disposable electronic cigarettes show that several popular brands (such as those utilizing leaded bronze or brass internal components) release toxic heavy metals at concentrations orders of magnitude higher than conventional combustible cigarettes. Mass-balance and aerosol emission studies have demonstrated that individual disposable vapes can contain and aerosolize hundreds of micrograms of lead (up to ~500 µg per device), whereas mainstream smoke from 20 packs of combustible cigarettes (400 cigarettes) typically yields roughly 4 to 20 µg of lead total.
- supports: Elevated Toxic Element Emissions from Popular Disposable E‑Cigarettes: Sources, Life Cycle… (ACS central science 2025) · cited 28x in the literature
"We report excessive emissions of toxic metallic elements in aerosols from flavored and "clear" versions of three popular products (Esco Bar, Flum Pebble, and ELF Bar), orders of magnitude higher in concentration than traditional cigarettes and other e-cigarettes." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Aluminium, copper, nickel, lead and zinc in e-liquids from contemporary disposable vapes. (Environmental monitoring and assessment 2026)
"mass balance calculations comparing e-liquids from new and used products of the same brand and flavour suggest that, per device, up to 8000 µg, 500 µg and 6000 µg of Cu, Pb and Zn, respectively, could be inhaled." (abstract, results)
pubmedfull study (doi)
Zyn nicotine pouches contain sodium carbonate to raise pH and convert nicotine into its freebase form for enhanced gum absorption.
"Zyn pouches use sodium carbonate, a base, to increase the pH of nicotine, converting it to its freebase form. This leads to increased absorption rates through your gums." (said at 0:23:06)
The host's statement accurately describes the biochemical formulation and mechanism of oral nicotine products like Zyn. Nicotine is a weak base, and its absorption across mucosal membranes (such as the gums) depends on its ionization state. At lower pH levels, nicotine exists predominantly in its ionized (protonated) state, which does not easily cross cell membranes. Adding alkaline agents such as sodium carbonate increases the product's pH, shifting nicotine into its non-ionized (freebase) form, which rapidly diffuses across the oral mucosa into systemic circulation. Clinical pharmacokinetic studies confirm that raising the pH of oral tobacco and nicotine formulations using sodium carbonate directly increases buccal nicotine absorption.
- supports: Nicotine Absorption from Smokeless Tobacco Modified to Adjust pH. (Journal of addiction research & therapy 2014) · cited 51x in the literature
"The rapid delivery of nicotine from ST seems to be associated with the pH of the aqueous suspension of the products - high pH is associated with high nicotine absorption... the pH was amended to either high (8.3) or low (5.4) pH with sodium carbonate or citric acid, respectively. In a within-subject clinical study, the higher pH products delivered more nicotine... These results indicate that pH is a primary determinant of buccal nicotine absorption." (abstract, background and results)
pubmedfull study (doi) - supports: Pharmacokinetic Comparison of a Novel Non-tobacco-Based Nicotine Pouch (ZYN) With Conventi… (Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2020) · cited 112x in the literature
"The present study demonstrates the characteristics of three strengths of a novel tobacco-free oral snus, ZYN, viz. the extraction of nicotine from the oral cavity and its uptake into the systemic blood circulation." (abstract, background, passage verified)
pubmedfull study (doi) - supports: Formulation of smokeless tobacco products with a wide range of pH to study nicotine pharma… (Pharmaceutical development and technology 2022) · cited 2x in the literature
"A commercial ST product (Copenhagen Long Cut Original, pH 7.7) was modified with citric acid monohydrate (23 mg/g tobacco) or sodium carbonate (4.6 and 11 mg/g) to create products with pH 5.0, 8.2, and 8.6, respectively." (abstract, methods, passage verified)
pubmedfull study (doi)
Only 3% to 5% of people attempting to quit nicotine cold turkey succeed without assistance.
"Only 3 to 5% of people are going to be successful at this, which is why packaging of things like this as benign or nootropic are so sinister." (said at 0:26:49)
The statement that only 3% to 5% of individuals succeed in quitting nicotine cold turkey (unassisted) aligns with benchmark long-term abstinence rates established in systematic reviews and clinical trials. Cochrane systematic reviews of smoking cessation interventions generally benchmark the long-term (6- to 12-month) unassisted quit rate at approximately 2% to 3%, with meta-analyses of control cohorts showing cessation rates without formal intervention typically ranging from 3% to 7%.
A 2012 Harvard study of 84,000 women from the Nurses' Health Study published in the Archives of Internal Medicine found that regular red meat consumption, especially processed meat, contributes substantially to premature death.
"In 2012, there was a study published from Harvard University in the Archives of Internal Medicine. This study looked at the relationship between red meat consumption and longevity and overall health in 84,000 women from the Nurses' Health Study. This study provides clear evidence that regular consumption of red meat, especially processed meat, contributes substantially to premature death." (said at 0:01:12)
A 2012 prospective cohort analysis led by Harvard researchers (Pan et al.) published in the Archives of Internal Medicine analyzed 83,644 women from the Nurses' Health Study (as well as 37,698 men from the Health Professionals Follow-up Study). The study found that each additional daily serving of red meat was associated with a 13% increased risk of total mortality for unprocessed red meat (HR 1.13, 95% CI 1.07–1.20) and a 20% increased risk for processed red meat (HR 1.20, 95% CI 1.15–1.24), alongside elevated cardiovascular and cancer mortality. Because the findings are derived from observational cohort data, the certainty of evidence for causality is low.
Nitrates added to processed meat form potentially carcinogenic compounds in the human gut to a significantly greater degree than unprocessed red meat.
"I think there is a case to be made that when you put a bunch of nitrates into processed meat, those nitrates are going to be much more avidly forming compounds in the human gut that could lead to carcinogenesis and cancer. What we know about unprocessed red meat is that those compounds don't get formed to the same degree when you eat that food" (said at 0:02:25)
Human dietary intervention evidence demonstrates that processed meat containing nitrites/nitrates leads to significantly higher endogenous formation of apparent total N-nitroso compounds (ATNC)—potentially carcinogenic compounds—in the human gastrointestinal tract compared to unprocessed red meat. In a controlled crossover trial in human volunteers, consuming 240 g/day of processed meat produced significantly higher ATNC output in ileal fluids (1832 µg/kg) than consuming 240 g/day of unprocessed fresh red meat (1175 µg/kg), though both formed substantially more ATNC than a non-meat baseline (283 µg/kg).
In the 2012 Harvard study, the cohort consuming the highest amounts of unprocessed red meat smoked more, drank more alcohol, exercised less, had higher body weights, and had more pre-existing chronic health conditions.
"If you look closely at the cohort of people eating more unprocessed red meat in this Harvard study that Frank Hu says is clear evidence that meat shortens your life, they're also smoking more, drinking more alcohol, exercising less, they're fatter, and they had more chronic health conditions existing at the same time." (said at 0:04:05)
In the 2012 Harvard prospective cohort study led by Pan, Frank Hu, and colleagues (PMID 22412075), participants with higher red meat consumption differed substantially in baseline lifestyle characteristics: they smoked more, consumed more alcohol, had higher body mass index, and engaged in less physical activity. Although participants with major cardiovascular disease and cancer were excluded at baseline, the authors adjusted for these confounding lifestyle factors and baseline health covariates in their multivariable mortality analyses.
The UK Shopper Study found that meat eaters and vegetarians had similar rates of all-cause mortality when healthy behaviors in vegetarians were accounted for.
"There's a well-known study from the UK colloquially known as the UK shopper study that came to the conclusion that meat eaters and vegetarians had similar rates of all-cause mortality when the healthy behaviors in the vegetarians were accounted for." (said at 0:05:05)
The Health Food Shoppers Study, alongside the Oxford Vegetarian Study, compared mortality between vegetarians and health-conscious non-vegetarians in the UK. Both groups showed significantly lower all-cause mortality compared to the general population (standardized mortality ratio of ~59%), but when vegetarians were compared directly with non-vegetarians within the cohort (adjusting for age, sex, and smoking), there was no significant difference in all-cause mortality (death rate ratio 1.03, 95% CI 0.95–1.13). The authors concluded that much of the longevity benefit observed in vegetarians is attributable to shared healthy lifestyle characteristics—such as low smoking rates and socioeconomic factors—rather than the avoidance of meat itself.
- supports: Mortality in British vegetarians. (Public health nutrition 2002) · cited 62x in the literature
"For all causes of death, the DRR for vegetarians compared with non-vegetarians was close to one in both studies: 1.01 (95% CI 0.89-1.14) in the Oxford Vegetarian Study, 1.03 (0.95-1.13) in the Health Food Shoppers Study. British vegetarians have low mortality compared with the general population. Their death rates are similar to those of comparable non-vegetarians, suggesting that much of this benefit may be attributed to non-dietary lifestyle factors such as a low prevalence of smoking and a generally high socio-economic status, or to aspects of the diet other than the avoidance of meat and fish." (abstract, results and conclusions, passage verified)
pubmedfull study (doi) - supports: Mortality in British vegetarians: review and preliminary results from EPIC-Oxford. (The American journal of clinical nutrition 2003) · cited 97x in the literature
"Comparing vegetarians with nonvegetarians within each cohort, the death rate ratios (DRRs), adjusted for age, sex and smoking, were 1.03 (0.95, 1.13) in the Health Food Shoppers Study, 1.01 (0.89, 1.14) in the Oxford Vegetarian Study, and 1.05 (0.86, 1.27) in EPIC-Oxford." (abstract, results, passage verified)
pubmedfull study (doi)
The Australian 45 and Up Study of over 267,000 individuals found no difference in longevity between meat eaters, vegans, and vegetarians.
"Another study from Australia looking at over 267,000 individuals looked at longevity in meat eaters, vegans, and vegetarians, and found no difference between them. This is what the news won't tell you guys. This is known as the 45 and Up study." (said at 0:05:37)
A prospective analysis from the Australian 45 and Up Study (Mihrshahi et al., 2017) examined 243,096 participants aged 45 and older from an overall cohort of 267,180 individuals over an average of 6.1 years of follow-up. After adjusting for potential confounding lifestyle and demographic factors, the researchers found no statistically significant difference in all-cause mortality between regular meat eaters and vegetarians (HR = 1.16, 95% CI: 0.93–1.45), semi-vegetarians (HR = 1.12, 95% CI: 0.96–1.31), or pesco-vegetarians (HR = 0.79, 95% CI: 0.59–1.06).
- supports: Vegetarian diet and all-cause mortality: Evidence from a large population-based Australian… (Preventive medicine 2017) · cited 83x in the literature
"Following extensive adjustment for potential confounding factors there was no significant difference in all-cause mortality for vegetarians versus non-vegetarians [HR=1.16 (95% CI 0.93-1.45)]. There was also no significant difference in mortality risk between pesco-vegetarians [HR=0.79 (95% CI 0.59-1.06)] or semi-vegetarians [HR=1.12 (95% CI 0.96-1.31)] versus regular meat eaters. We found no evidence that following a vegetarian diet, semi-vegetarian diet or a pesco-vegetarian diet has an independent protective effect on all-cause mortality." (abstract, results, passage verified)
pubmedfull study (doi)
A pooled cohort study from Asia involving over 290,000 people showed correlations between red meat consumption and improved health outcomes.
"There are multiple cohorts including this one from Asia where this meat as unhealthy narrative is nothing like it is in the United States. 290,000 plus people that show correlations between red meat consumption and improved health outcomes fly in the face of what the Harvard study shown." (said at 0:06:08)
A 2013 pooled analysis of 8 prospective cohort studies across Asia (Bangladesh, China, Japan, Korea, and Taiwan) involving 296,721 participants (112,310 men and 184,411 women) evaluated meat consumption and mortality. The researchers observed that red meat intake was inversely associated with cardiovascular disease mortality in men and cancer mortality in women, contrasting with findings typically reported in Western cohorts.
- supports: Meat intake and cause-specific mortality: a pooled analysis of Asian prospective cohort st… (The American journal of clinical nutrition 2013) · cited 147x in the literature
"Separately, 8 Asian prospective cohort studies in Bangladesh, China, Japan, Korea, and Taiwan consisting of 112,310 men and 184,411 women were followed for 6.6 to 15.6 y with 24,283 all-cause, 9558 cancer, and 6373 cardiovascular disease (CVD) deaths... Red meat intake was inversely associated with CVD mortality in men and with cancer mortality in women in Asian countries." (abstract, methods and results, passage verified)
pubmedfull study (doi)
The 2019 NutriRECS guidelines examined evidence regarding red meat and human health and found no reason to recommend that humans reduce red meat intake.
"In 2019, a group of scientists from around the world published the NutriRECS guidelines. They examined all of the evidence around red meat and health and longevity for humans and came to the conclusion that there was no reason to stop eating red meat." (said at 0:06:39)
The 2019 Nutritional Recommendations (NutriRECS) Consortium guideline systematically reviewed evidence on unprocessed red meat and processed meat consumption across multiple health outcomes (including mortality, cardiovascular disease, and cancer). The international panel concluded with a weak recommendation that adults continue their current consumption of unprocessed red meat and processed meat, citing low-certainty evidence for any meaningful reduction in risk from decreasing intake alongside people's values and preferences.
The 2021 PURE study of 134,000 people across 21 countries found no correlation between unprocessed red meat intake and negative health outcomes, finding an association only with processed red meat.
"Another super important study from 2021, known as the PURE study, looked at 134,000 people across 21 countries, and there was essentially no correlation between unprocessed red meat and any negative health outcomes. The only association was found with processed red meat." (said at 0:07:15)
The 2021 Prospective Urban Rural Epidemiology (PURE) cohort study evaluated 134,297 individuals across 21 low-, middle-, and high-income countries over a median follow-up of 9.5 years. The authors found that higher intake of unprocessed red meat was not significantly associated with total mortality or major cardiovascular disease events, whereas higher intake of processed meat was significantly associated with higher risks of both total mortality and major cardiovascular disease.
A 2022 analysis published in Nature Medicine concluded that the association between red meat consumption and adverse health outcomes was weak.
"And in 2022, in the journal Nature Medicine, which is a hugely prestigious journal, there was another analysis of all the data of red meat and health that came to the exact same conclusion. The connection between red meat and adverse health outcomes was weak, not strong, weak at best." (said at 0:07:39)
A 2022 systematic review and meta-regression published in Nature Medicine by the Institute for Health Metrics and Evaluation (the Burden of Proof study) evaluated the relationship between unprocessed red meat consumption and six chronic health outcomes. The authors reported weak evidence of an association between unprocessed red meat consumption and colorectal cancer, breast cancer, type 2 diabetes, and ischemic heart disease, and no evidence of an association with ischemic or hemorrhagic stroke, concluding that the available evidence linking unprocessed red meat to increased disease risk is weak.
- supports: Health effects associated with consumption of unprocessed red meat: a Burden of Proof stud… (Nature medicine 2022) · cited 172x in the literature
"We found weak evidence of association between unprocessed red meat consumption and colorectal cancer, breast cancer, type 2 diabetes and ischemic heart disease. Moreover, we found no evidence of an association between unprocessed red meat and ischemic stroke or hemorrhagic stroke. ... While there is some evidence that eating unprocessed red meat is associated with increased risk of disease incidence and mortality, it is weak and insufficient to make stronger or more conclusive recommendations." (abstract, results and conclusions, passage verified)
pubmedfull study (doi)
A 2025 case-control study from China found that vegans and vegetarians were less likely to reach age 100 than meat eaters.
"A more recent 2025 case-control study from China found that vegans and vegetarians were less likely to reach age 100 than meat eaters." (said at 0:08:41)
A prospective nested case-control study of 5,203 Chinese adults aged 80 and older from the Chinese Longitudinal Healthy Longevity Survey evaluated the relationship between dietary patterns and reaching age 100. Compared to omnivores, participants following a vegetarian diet had a significantly lower likelihood of becoming centenarians (OR 0.81, 95% CI 0.69–0.96), with a similar lower likelihood observed specifically among vegans (OR 0.71, 95% CI 0.54–0.98).
- supports: Vegetarian diet and likelihood of becoming centenarians in Chinese adults aged 80 y or old… (The American journal of clinical nutrition 2026) · cited 2x in the literature
"Relative to omnivores, vegetarians had a lower likelihood of becoming centenarians [odds ratio (OR): 0.81, 95% confidence interval (CI): 0.69, 0.96], and similar patterns were observed for vegans (OR: 0.71, 95% CI: 0.54, 0.98), but not for pesco-vegetarians (OR: 0.84, 95% CI: 0.64, 1.09) and ovo-lacto-vegetarians (OR: 0.86, 95% CI: 0.67, 1.09)." (abstract, results, passage verified)
pubmedfull study (doi)
Taurine, anserine, creatine, carnosine, vitamin B12, and 4-hydroxyproline are dietary nutrients that occur only in animal foods and are absent from plant sources.
"So, you've got taurine, anserine, creatine, carnosine, B12, and 4-hydroxyproline... It's just those six are only available in animal foods, and they're associated with good health outcomes." (said at 0:12:46)
Nutritional analyses confirm that taurine, creatine, carnosine, and anserine are virtually absent from plant-based foods, 4-hydroxyproline is present only in negligible amounts, and bioavailable vitamin B12 naturally occurs in animal-derived foods rather than unfortified plant foods. These bioactive compounds are abundant in animal-source foods and play recognized physiological roles in metabolic, neurological, and cardiovascular health.
- supports: Composition of polyamines and amino acids in plant-source foods for human consumption. (Amino acids 2019) · cited 150x in the literature
"All of the analyzed plant-source foods lacked taurine, creatine, carnosine and anserine (antioxidants that are abundant in meats and also present in milk), and contained little 4-hydroxyproline." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Important roles of dietary taurine, creatine, carnosine, anserine and 4-hydroxyproline in … (Amino acids 2020) · cited 480x in the literature
"Of particular note, taurine, carnosine, anserine, and creatine are absent from plants, and hydroxyproline is negligible in many plant-source foods." (abstract, results, passage verified)
pubmedfull study (doi)
A 2023 study published in Science found that taurine supplementation extended lifespan in mice by 10 to 12 percent.
"So, there's a paper from 2023 published in the journal Science, one of the most preeminent, impactful journals in the world. And the title of this study was compelling. Taurine deficiency as a driver of aging. In this study, they gave mice, monkeys, and worms, not humans, unfortunately, taurine supplementation and looked at their lifespan. What did they find? Taurine supplementation extended lifespan across species. You might recognize the Latin root taurus or bull is found in animal foods. So, when they gave taurine to mice, they lived 10 to 12% longer." (said at 0:14:20)
A landmark 2023 study published in Science by Singh et al. ('Taurine deficiency as a driver of aging') tested taurine supplementation across multiple model organisms. The authors observed that circulating taurine declined with age across species and that oral taurine supplementation fed to middle-aged mice significantly increased median lifespan by 10% to 12% (and increased healthspan in mice and monkeys, and lifespan in worms and mice). Because the evidence is derived from animal and cell models, certainty for translational human longevity outcomes is rated very low.
Carnosine is a dipeptide of beta-alanine and histidine that is not found in plants.
"So, carnosine is a dipeptide, it's beta-alanine plus histidine, and it is only found in animal foods. There is no carnosine in plants." (said at 0:17:47)
Carnosine is well-established as a dipeptide composed of beta-alanine and histidine. It is concentrated in animal tissues (particularly skeletal muscle and brain) and is absent from plant sources.
A 2019 trial showed that combined carnosine and anserine supplementation improved cognitive outcomes in individuals carrying the APOE4 polymorphism.
"And a separate 2019 trial showed carnosine supplementation with anserine, another one of these big six nutrients, improved cognitive outcomes in people with the APOE4 polymorphism. That's the genetic polymorphism that is associated with an increased rate of Alzheimer's disease." (said at 0:19:19)
A 2019 randomized, double-blind, placebo-controlled trial evaluated daily supplementation with 750 mg anserine and 250 mg carnosine versus placebo for 12 weeks in 54 older adults with mild cognitive impairment (MCI). In subgroup analysis based on APOE genotype, participants carrying the APOE4 allele in the active supplement group showed statistically significant improvements compared to placebo in both the global Clinical Dementia Rating (gloCDR, p = 0.026) and the Mini-Mental State Examination (MMSE, p = 0.025).
A recent study found that greater consumption of unprocessed red meat was associated with improved outcomes in people carrying APOE4 single nucleotide polymorphisms.
"And interestingly, there was a study that was just published in the last year that showed that more consumption of unprocessed red meat was associated with improved outcomes in people with APOE4 single nucleotide polymorphisms." (said at 0:19:37)
Observational cohort studies have reported associations between unprocessed red meat intake and improved cognitive outcomes, including analyses stratifying by APOE4 status. In a UK Biobank analysis of 1,787 participants evaluating 10-year cognitive trajectories, weekly lamb consumption was associated with improved fluid intelligence scores among APOE4 carriers. A larger UK Biobank analysis (n = 493,888) similarly found that higher unprocessed red meat intake was associated with a reduced risk of incident all-cause dementia and Alzheimer's disease, although APOE4 status did not significantly modify the relationship. Because these findings come from observational cohort studies relying on self-reported dietary questionnaires, certainty is low and cannot establish causality.
- supports: Genetic Factors of Alzheimer's Disease Modulate How Diet is Associated with Long-Term Cogn… (Journal of Alzheimer's disease : JAD 2020) · cited 34x in the literature
"Consuming lamb weekly was associated with improved outcomes (FH-: β= 0.066, p = 0.008; ɛ4+: β= 0.097, p = 0.044)." (abstract, results, passage verified)
pubmedfull study (doi) - context: Meat consumption and risk of incident dementia: cohort study of 493,888 UK Biobank partici… (The American journal of clinical nutrition 2021) · cited 133x in the literature
"In contrast, a 50-g/d increment in unprocessed red meat intake was associated with reduced risks of all-cause dementia (HR: 0.81; 95% CI: 0.69, 0.95; P-trend = 0.011) and AD (HR: 0.70; 95% CI: 0.53, 0.92; P-trend = 0.009)... The APOE ε4 allele increased dementia risk by 3 to 6 times but did not modify the associations with diet significantly." (abstract, results, passage verified)
pubmedfull study (doi)
Dietary glycine supplementation extends lifespan in animal models.
"If you look at the research on glycine specifically, glycine extends lifespan in animal models." (said at 0:20:18)
Dietary glycine supplementation has been shown to extend median and maximum lifespan in rodent models. In a multi-site randomized study conducted by the National Institute on Aging (NIA) Interventions Testing Program in genetically heterogeneous mice (UM-HET3), an 8% dietary glycine supplement produced a statistically significant 4% to 6% increase in median lifespan, as well as an increase in maximum lifespan, in both male and female mice.
Being under-muscled is associated with a 50% to 75% increase in all-cause mortality across studies.
"Across all studies, being under muscled looks to increase your mortality by 50 to 75%. That's a huge risk." (said at 0:23:22)
Large systematic reviews and meta-analyses of prospective cohort studies support the claim. In meta-analyses evaluating low muscle mass or lean mass indices and all-cause mortality, low muscle mass is consistently associated with an approximate 40% to 75% increase in the risk of all-cause mortality. For example, a meta-analysis of 16 prospective cohort studies found a pooled relative risk of 1.57 (a 57% increase) comparing low to normal skeletal muscle mass index, and another comprehensive meta-analysis of cohort studies reported a pooled hazard ratio of 1.74 (a 74% increase) for individuals classified with low lean mass cutoff criteria.
Elevated LDL cholesterol levels are associated with a 10% to 30% increased risk of mortality.
"In contrast, LDL has been shown to suggest a 10 to 30% risk of mortality at higher levels." (said at 0:23:30)
Large cohort studies and meta-analyses show that elevated LDL cholesterol levels are associated with an increased risk of all-cause mortality in the range of 10% to 34%. For example, a prospective cohort study of 108,243 individuals in Denmark found a multivariable-adjusted hazard ratio for all-cause mortality of 1.15 (95% CI: 1.05 to 1.27, a 15% increase) for LDL-C concentrations >4.8 mmol/L (>189 mg/dL) compared to optimal levels. Similarly, a 2022 meta-analysis of 20 cohort studies with over 1.2 million participants found that LDL-C ≥160 mg/dL was associated with a 34% higher risk of all-cause mortality (RR 1.34, 95% CI: 1.00 to 1.80). Because these estimates derive from observational cohort studies rather than randomized trials, the GRADE certainty is rated as low.
- supports: Association between low density lipoprotein and all cause and cause specific mortality in … (BMJ (Clinical research ed.) 2020) · cited 262x in the literature
"Compared with individuals with concentrations of LDL-C of 3.4-3.9 mmol/L (132-154 mg/dL; 61st-80th centiles), the multivariable adjusted hazard ratio for all cause mortality was 1.25 (95% confidence interval 1.15 to 1.36) for individuals with LDL-C concentrations of less than 1.8 mmol/L (<70 mg/dL; 1st-5th centiles) and 1.15 (1.05 to 1.27) for LDL-C concentrations of more than 4.8 mmol/L (>189 mg/dL; 96th-100th centiles)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Association of low-density lipoprotein cholesterol levels with the risk of mortality and c… (Medicine 2022) · cited 24x in the literature
"The risks of all-cause mortality (RR: 1.34, 95%CI: 1.00-1.80), CVD death (RR: 1.79, 95%CI: 1.26-2.54), CHD death (RR: 2.03, 95%CI: 1.36-3.03) were higher in LDL-C ≥ 160 mg/dL than LDL-C of 70-129 mg/dL." (abstract, results, passage verified)
pubmedfull study (doi)
A 2.5 to 3 gram dose of leucine can be obtained from approximately 30 grams of whey protein or 40 to 50 grams of protein from red meat.
"You can get 2 and 1/2 to 3 g of leucine from 30-ish g of whey protein. You can get it in 40 to 50 g of protein from red meat, but you're going to have to eat a lot more soybeans, a lot more peas, a lot more rice and beans, and a ton of lentils, and a whole lot of tofu that's going to give you a stomachache to get that amount of leucine." (said at 0:24:47)
The speaker's estimates are accurate according to standard nutritional and amino acid composition data. Whey protein is approximately 11% to 13% leucine by weight of protein (meaning ~25–30 g of whey protein yields roughly 2.7–3.6 g of leucine), while beef and red meat protein contain approximately 8% leucine (meaning 35–50 g of protein from beef yields roughly 2.8–4.0 g of leucine). Plant-based proteins generally contain lower proportions of leucine (roughly 6–8% of total protein) and lower protein density per unit mass, necessitating substantially higher total volume or total protein intake to achieve a 2.5–3 g leucine threshold.
Fact-checked episodes
Publications
No PubMed publication profile has been built for this speaker yet.